How a gene mutation makes an enzyme hyperactive

Original Title

Disease-Associated Mutation A554V Disrupts Normal Autoinhibition of DNMT1

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Scientists studied a specific mutation (A554V) in DNMT1, an enzyme that adds methyl groups to DNA. This mutation is linked to adult-onset neurodegenerative disorders. The mutation disrupts a normal 'brake' mechanism (RFTS domain) that keeps DNMT1 inactive until needed.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

The isolated RFTS domain appears completely normal despite causing disease

You'd expect the mutation to directly damage the RFTS domain since that's where the mutation occurs. Instead, the mutation weakens the interaction between RFTS and the methyltransferase domain—affecting how the two parts talk to each other.

Practical Takeaways

This research could inform drug design targeting the DNMT1-RFTS interaction

medium - well-designed biochemical study but lacks in vivo validation confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.